FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype